CR:DOI:9a9e7f94d3dbf38ac747d552bbdff29e

{{#scite:
 |reference=trubiano2017in
 |type=journal-article
 |title=Incidence, etiology and timing of infections following azacitidine therapy for myelodysplastic syndromes
 |author=Jason A. Trubiano;Michael Dickinson;Karin A. Thursky;Timothy Spelman;John F. Seymour;Monica A. Slavin;Leon J. Worth|+sep=;
 |journal=Leukemia & Lymphoma
 |publisher=Informa UK Limited
 |year=2017
 |volume=58
 |issue=10
 |pages=2379-2386
 |doi=10.1080/10428194.2017.1295141
 |subject=Cancer Research;Oncology;Hematology|+sep=;
 |issn=1042-8194;1029-2403|+sep=;
 |retrieved-from=https://dx.doi.org/
 |retrieved-on=2022-02-24
}}